MUSTANG BIO, INC. Adjustments to Additional Paid in Capital, Warrant Issued
MUSTANG BIO, INC. (MBIO) reported Adjustments to Additional Paid in Capital, Warrant Issued of $793.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-29.
Discontinued › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2018-03-29
- MUSTANG BIO, INC. adjustments to additional paid in capital, warrant issued for fiscal 2016 was $793.00K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|
| 2016-12-31 | $793.00K 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |